Phase I/II adenoviral p53 gene therapy for chemoradiation resistant advanced esophageal squamous cell carcinoma

• SHIMADA Hideaki

  Department of Frontier Surgery, Chiba University Graduate School of Medicine

• MATSUBARA Hisahiro

  Department of Frontier Surgery, Chiba University Graduate School of Medicine

• SHIRATORI Tooru

  Department of Frontier Surgery, Chiba University Graduate School of Medicine

• SHIMIZU Takanori

  Department of Frontier Surgery, Chiba University Graduate School of Medicine

• MIYAZAKI Shinichi

  Department of Frontier Surgery, Chiba University Graduate School of Medicine

• OKAZUMI Shinichi

  Department of Frontier Surgery, Chiba University Graduate School of Medicine

• NABEYA Yoshihiro

  Department of Frontier Surgery, Chiba University Graduate School of Medicine

• SHUTO Kiyohiko

  Department of Frontier Surgery, Chiba University Graduate School of Medicine

• HAYASHI Hideki

  Research Center for Frontier Engineering, Chiba University

• TANIZAWA Tooru

  Department of Pathology, Chiba University Hospital

• NAKATANI Yukio

  Department of Pathology, Chiba University Hospital

• NAKASA Hiromitsu

  Division of Pharmacy, Chiba University Hospital

• KITADA Mitsukazu

  Division of Pharmacy, Chiba University Hospital

• OCHIAI Takenori

  Department of Frontier Surgery, Chiba University Graduate School of Medicine

Journal

• Cancer Sci

  Cancer Sci 97 (6), 554-561, 2006-06-10

Details

• CRID: 1571698600339801216
• NII Article ID: 10018176565
• NII Book ID: AA11808050
• ISSN: 13479032
• Web Site: https://search.jamas.or.jp/link/ui/2007079046
• Text Lang: en
• Data Source:
  • CiNii Articles